Resolving Life Science Collaboration Disputes


This article first appeared in Law360, May 11, 2012.

Life science companies frequently collaborate to develop drugs or devices. Some collaboration agreements refer disputes to arbitration. Others are silent so any disputes go to court.

On the whole, arbitration works better to resolve disputes that occur during the collaboration, while court litigation works at least as well and maybe better to resolve disputes that occur after the collaboration ceases.

As a result, collaborators should consider agreeing that disputes be submitted to arbitration if the arbitration request is filed before the collaboration terminates or to resolve a dispute about whether the collaboration has been terminated, but that any later disputes proceed to court.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Alternative Dispute Resolution (ADR) Updates, General Business Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pillsbury Winthrop Shaw Pittman LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »